SynCore Biotechnology Co

SynCore Biotechnology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SynCore Biotechnology Co (4192.TWO) as of Nov 11, 2026 is -47.20 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -57.76 M TWD — a change of -18.28% (higher).

EBITDA

-47.20 MTWD

YoY

-18.28%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SynCore Biotechnology Co is 2025 -47.20 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SynCore Biotechnology Co was 2024 -57.76 M TWD. It decreases by -18.28% higher compared to the previous year.

The SynCore Biotechnology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-301.02 M TWD
Jan 1, 2019
-416.59 M TWD
Jan 1, 2020
-396.77 M TWD
Jan 1, 2021
-457.59 M TWD
Jan 1, 2022
-187.82 M TWD
Jan 1, 2023
-37.39 M TWD
Jan 1, 2024
-57.76 M TWD
Jan 1, 2025
-47.20 M TWD
The SynCore Biotechnology Co EBITDA history
YEAREBITDAYoY
-47.20 MTWD-18.28%
-57.76 MTWD+54.48%
-37.39 MTWD-80.09%
-187.82 MTWD-58.95%
-457.59 MTWD+15.33%
-396.77 MTWD-4.76%
-416.59 MTWD+38.39%
-301.02 MTWD+15.78%
-260.00 MTWD+6.70%
-243.67 MTWD+18.42%
-205.77 MTWD-19.86%
-256.78 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SynCore Biotechnology Co Stock analysis

What does SynCore Biotechnology Co do? SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan. SynCore Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SynCore Biotechnology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SynCore Biotechnology Co is -47.20 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of SynCore Biotechnology Co changed from -57.76 M TWD to -47.20 M TWD, representing a -18.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) SynCore Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s SynCore Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — SynCore Biotechnology Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — SynCore Biotechnology Co